Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz

This expanded partnership solidifies Just – Evotec Biologics’ commitment to providing long-term commercial supply of biosimilars to Sandoz from its newly built J.POD® biologics manufacturing facility at Evotec’s Campus Curie in Toulouse, France. Sandoz secures further guarantees relating to long-term supply for patients with a reservation of significant commercial manufacturing capacity. 

Since May 2023, Just – Evotec Biologics and Sandoz have been engaged in a multi-year technology partnership aimed at the rapid development and manufacturing of biosimilars. Leveraging its data-driven, fully integrated design capability and continuous manufacturing technology platform (J.DESIGN), Just – Evotec Biologics aims to deliver the highest product quality and cost efficiency to its partners.

The post Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz appeared first on Life Science Washington.

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks